Talazoparib Oral Capsule

DRUG2 trials

Sponsors

Brown University, Seoul National University Hospital

Conditions

Advanced Breast CancerBRCA1 MutationBRCA2 MutationFallopian Tube CancerHigh Grade Serous CarcinomaOvarian Cancer

Phase 1

BrUOG 390: Neoadjuvant Treatment With Talazoparib

TerminatedNCT04598321

Brown UniversityBRCA1 Mutation, BRCA2 Mutation, Fallopian Tube Cancer +2

Start: 2021-03-29End: 2022-12-06Updated: 2023-10-12

Phase 2

Talazoparib in Advanced Breast Cancer Patients With Homologous Recombinant Deficiency

RecruitingNCT04892693

Seoul National University HospitalAdvanced Breast Cancer

Start: 2021-05-25End: 2027-05-31Target: 70Updated: 2025-04-17